The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 6
Results: 10
1
2
Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis.
- Published in:
- Drug Safety, 2021, v. 44, n. 6, p. 645, doi. 10.1007/s40264-021-01057-z
- By:
- Publication type:
- Article
3
Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
4
The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.
- Published in:
- 2021
- By:
- Publication type:
- journal article
6
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.
- Published in:
- 2021
- By:
- Publication type:
- journal article
7
Correction to: Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
8
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
9
Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event.
- Published in:
- 2021
- By:
- Publication type:
- journal article
10
Comparison of Medication Alerts from Two Commercial Applications in the USA.
- Published in:
- 2021
- By:
- Publication type:
- journal article